The Twenty-First Annual Infectious Diseases in Children Symposium

Course Director
Philip A. Brunell, MD
Chief Medical Editor
Infectious Diseases in Children

NOVEMBER 22-23, 2008; New York Marriott Marquis; Times Square, New York City

Celebrating more than 20 years as the essential symposium for pediatric professionals

Since 1987, the Infectious Diseases in Children Symposium has educated more than 9,000 physicians, nurses and administrators. The tradition continues this year with program sessions designed to enhance your learning experience.

At the conclusion of this activity, attendees should be able to:

Identify ways to diagnose and treat respiratory infections in the light of current epidemiology.
Recognize current challenges in vaccine administration.
Identify skin infections in the newborn and older child to effectively treat.
Explain how to communicate key diagnostic, prevention and treatment options of adolescent STDs.
Express better management of common pediatric problems.
Translate the latest information on the diagnosis and treatment of UTI in pediatric practice.

This CME activity is jointly sponsored by

and

ACCREDITATION: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Vindico Medical Education and Infectious Diseases in Children. Vindico Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION: Vindico Medical Education designates this educational activity for a maximum of 12 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

FACULTY/PLANNER DISCLOSURE POLICY: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.